{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-018990","form_type":"8-K","ticker":"PLX","cik":"0001006281","company_name":"Protalix BioTherapeutics, Inc.","filed_at":"2022-12-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.194579+00:00","generated_at":"2026-06-20T22:40:42.293223+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Protalix BioTherapeutics sets March 22, 2023 for TASE delisting; will remain on NYSE American","bullets":["Delisting from Tel Aviv Stock Exchange effective March 22, 2023; last trading day March 20, 2023.","Common stock will continue to be listed and trade on NYSE American under symbol PLX.","Israeli shareholders urged to contact their brokers to transfer shares to a NYSE American-based account."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-018990","json":"https://secwatch.observer/filing/0001558370-22-018990.json","markdown":"https://secwatch.observer/filing/0001558370-22-018990.md","text":"https://secwatch.observer/filing/0001558370-22-018990.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006281/000155837022018990/0001558370-22-018990-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006281/000155837022018990/plx-20221227x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T22:40:42.293223+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}